ED431
发表于 2025-3-21 16:35:02
书目名称Dose-Finding Designs for Early-Phase Cancer Clinical Trials影响因子(影响力)<br> http://impactfactor.cn/if/?ISSN=BK0282679<br><br> <br><br>书目名称Dose-Finding Designs for Early-Phase Cancer Clinical Trials影响因子(影响力)学科排名<br> http://impactfactor.cn/ifr/?ISSN=BK0282679<br><br> <br><br>书目名称Dose-Finding Designs for Early-Phase Cancer Clinical Trials网络公开度<br> http://impactfactor.cn/at/?ISSN=BK0282679<br><br> <br><br>书目名称Dose-Finding Designs for Early-Phase Cancer Clinical Trials网络公开度学科排名<br> http://impactfactor.cn/atr/?ISSN=BK0282679<br><br> <br><br>书目名称Dose-Finding Designs for Early-Phase Cancer Clinical Trials被引频次<br> http://impactfactor.cn/tc/?ISSN=BK0282679<br><br> <br><br>书目名称Dose-Finding Designs for Early-Phase Cancer Clinical Trials被引频次学科排名<br> http://impactfactor.cn/tcr/?ISSN=BK0282679<br><br> <br><br>书目名称Dose-Finding Designs for Early-Phase Cancer Clinical Trials年度引用<br> http://impactfactor.cn/ii/?ISSN=BK0282679<br><br> <br><br>书目名称Dose-Finding Designs for Early-Phase Cancer Clinical Trials年度引用学科排名<br> http://impactfactor.cn/iir/?ISSN=BK0282679<br><br> <br><br>书目名称Dose-Finding Designs for Early-Phase Cancer Clinical Trials读者反馈<br> http://impactfactor.cn/5y/?ISSN=BK0282679<br><br> <br><br>书目名称Dose-Finding Designs for Early-Phase Cancer Clinical Trials读者反馈学科排名<br> http://impactfactor.cn/5yr/?ISSN=BK0282679<br><br> <br><br>
现存
发表于 2025-3-21 23:29:49
Model-Based Designs Considering Toxicity Alone,oses, and originate from the continual reassessment method (CRM). The present chapter provides a detailed description of the concepts, theories, properties, and advantages and disadvantages of the CRM, and also overview designs that are related to the CRM or that constitute extended versions of this method.
concubine
发表于 2025-3-22 03:18:04
Model-Assisted Designs Considering Toxicity Alone, before trial initiation. The model-assisted designs considering toxicity alone include, e.g., the modified toxicity probability interval (mTPI) design and its improved design (the mTPI-2 design), Bayesian optimal interval design, and keyboard design. In this chapter, we overview these designs and discuss related topics.
处理
发表于 2025-3-22 08:00:12
Designs for Early-Phase Immunotherapeutic Agent Trials,ical to successful treatment. Such doses are found by considering the outcome related to the immune response in addition to the toxicity and efficacy outcomes. This chapter reviews several dose-finding designs for early-phase immunotherapy trials.
LINE
发表于 2025-3-22 11:36:25
http://reply.papertrans.cn/29/2827/282679/282679_5.png
inquisitive
发表于 2025-3-22 15:45:45
http://reply.papertrans.cn/29/2827/282679/282679_6.png
inquisitive
发表于 2025-3-22 19:22:38
http://reply.papertrans.cn/29/2827/282679/282679_7.png
HACK
发表于 2025-3-22 21:16:07
Book 2019book or handbook for graduate students and practitioners in biostatistics and clinical investigators who are involved in designing, conducting, monitoring, and analyzing dose-finding trials. The book will also provide an overview of advanced topics and discussions in this field for the benefit of re
pancreas
发表于 2025-3-23 03:10:54
http://reply.papertrans.cn/29/2827/282679/282679_9.png
不容置疑
发表于 2025-3-23 06:48:09
http://reply.papertrans.cn/29/2827/282679/282679_10.png